cortechs.ai: Precision AI for Medical Imaging in Neurology and Oncology

cortechs.ai is a leading medical AI company with over 18 years of expertise in quantitative analysis of brain and prostate imaging, delivering clinically validated tools that enhance diagnostic accuracy and monitoring for neurological and oncological diseases. Trusted by more than 1,500 medical institutions across 44 countries, the platform leverages machine learning and a normative database with Dynamic Atlas™ technology to provide automated, high-precision volumetric and lesion analysis. Its FDA-cleared, cloud-native solutions—including NeuroQuant®, NeuroQuant® MS, NeuroQuant® Brain Tumor, NeuroQuant® for ARIA, NeuroQuant® PET, NeuroAlign CT, and OnQ™ Prostate—are designed to support radiologists, neurologists, urologists, and oncologists in making faster, more reliable clinical decisions. The company integrates seamlessly with PACS systems and supports reimbursement through Category III CPT codes, ensuring real-world usability and adoption in healthcare settings.

Key Features:

• NeuroQuant®: Clinical gold standard for MRI brain volume measurement with advanced segmentation and volumetric analysis.
• NeuroQuant® MS: Enables accurate visualization and tracking of lesion volume changes in multiple sclerosis.
• NeuroQuant® Brain Tumor: Supports pre- and post-operative 3D volume analysis of brain tumors (metastases, meningiomas, gliomas).
• NeuroQuant® for ARIA: Segments and tracks FLAIR, T2*GRE, and SWI lesions longitudinally for improved monitoring.
• NeuroQuant® PET: Delivers rapid, automated subregional tracer quantification in PET imaging.
• NeuroAlign CT: Automated CT software for fast and accurate diagnosis.
• OnQ™ Prostate: Uses patented Restriction Spectrum Imaging (RSI) to enhance prostate MRI with improved lesion conspicuity, accuracy, and inter-reader agreement.
• Dynamic Atlas™ Technology: Accounts for age and other covariates to ensure precise brain segmentation.
• Normative Database: Compares individual brain structure volumes to healthy population benchmarks.
• FDA-Cleared Solutions: Cloud-native tools with regulatory approval for clinical use.
• CPT Code Support: Backed by Category III CPT codes 0865T, 0866T, 0649T, and 76377 for reimbursement.
• Seamless PACS Integration: Designed for easy adoption in existing radiology workflows.
• Extensive Clinical Validation: Supported by published research, whitepapers, and real-world case studies.
• Zero Downtime Service: Ensures continuous availability for critical clinical operations.
• Global Reach & Partnerships: Works with major healthcare technology providers like Siemens Healthineers, Philips Healthcare, GE Healthcare, and Canon Medical.
• Comprehensive Support Resources: Includes a resource library, ticket submission system, feature suggestions, and expert-led training.

Pricing: While specific pricing details are not publicly listed, cortechs.ai offers enterprise-level solutions with support for reimbursement via CPT codes, indicating a subscription or usage-based model tailored to healthcare institutions. A free demo is available to explore capabilities, suggesting a trial-based onboarding approach.

Conclusion: With a proven track record of analyzing over 2 million brain scans and serving top-tier medical institutions worldwide, cortechs.ai stands at the forefront of AI-driven radiology, combining deep clinical expertise with cutting-edge technology to revolutionize diagnosis and monitoring in neurology and oncology.